COSCIENS Biopharma Correlations

CSCI Stock   2.90  0.05  1.75%   
The current 90-days correlation between COSCIENS Biopharma and Puma Biotechnology is 0.15 (i.e., Average diversification). The correlation of COSCIENS Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

COSCIENS Biopharma Correlation With Market

Significant diversification

The correlation between COSCIENS Biopharma and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding COSCIENS Biopharma and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in COSCIENS Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more detail on how to invest in COSCIENS Stock please use our How to Invest in COSCIENS Biopharma guide.

Moving together with COSCIENS Stock

  0.93VALN Valneva SE ADRPairCorr
  0.92ERNA Eterna TherapeuticsPairCorr
  0.9JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.79LLY Eli LillyPairCorr
  0.81MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.91PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr
  0.66INBX Inhibrx Symbol ChangePairCorr
  0.77SXTPW 60 Degrees PharmaceuPairCorr
  0.9MRVI Maravai LifesciencesPairCorr
  0.91REGN Regeneron PharmaceuticalsPairCorr
  0.74ABBV AbbVie IncPairCorr
  0.79AKAN Akanda CorpPairCorr
  0.93AMGN Amgen IncPairCorr
  0.74ANRO Alto Neuroscience,PairCorr
  0.7APGE Apogee Therapeutics,PairCorr
  0.68ARDX ArdelyxPairCorr
  0.7AVDL Avadel PharmaceuticalsPairCorr
  0.69SMMT Summit Therapeutics PLCPairCorr

Moving against COSCIENS Stock

  0.89BMY Bristol Myers SquibbPairCorr
  0.82ESPR Esperion TherapeuticsPairCorr
  0.74GILD Gilead SciencesPairCorr
  0.73DYAI Dyadic InternationalPairCorr
  0.49DNA Ginkgo Bioworks Holdings Sell-off TrendPairCorr
  0.7MNMD Mind MedicinePairCorr
  0.63ABCL Abcellera BiologicsPairCorr
  0.34MOLN Molecular PartnersPairCorr
  0.88TARS Tarsus PharmaceuticalsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
PTGXIOVA
SNDXIOVA
PTGXSNDX
  
High negative correlations   
PTGXPBYI
SNDXPBYI
IOVAPBYI

Risk-Adjusted Indicators

There is a big difference between COSCIENS Stock performing well and COSCIENS Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze COSCIENS Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

COSCIENS Biopharma Corporate Executives

Elected by the shareholders, the COSCIENS Biopharma's board of directors comprises two types of representatives: COSCIENS Biopharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of COSCIENS. The board's role is to monitor COSCIENS Biopharma's management team and ensure that shareholders' interests are well served. COSCIENS Biopharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, COSCIENS Biopharma's outside directors are responsible for providing unbiased perspectives on the board's policies.